Table of Content


Executive Summary
1 Market Overview
1.1 Types of Sports Injuries

2 Market Dynamics
2.1 Drivers
2.1.1 Growing Incidence of Sports Injuries
2.1.2 Increasing Popularity of Minimally Invasive Surgery
2.1.3 Increased Awareness About Implants
2.1.4 Continuous Launch of New Products
2.1.5 Increasing Number of Sports Medicine association
2.2 Restraints
2.2.1 High Cost of Treatment
2.2.2 Adverse Effects After Treatments
2.3 Opportunities
2.3.1 Development in the Field of Regenerative Medicine
2.3.2 Automation of Surgeries
2.3.3 Development of Advanced Materials

3 Competitive Landscape
3.1 Key Developmental Strategies
3.1.1 Acquisitions
3.1.2 Agreements, Collaborations and Partnerships
3.1.3 Clinical Studies
3.1.4 Others
3.2 Market Share Analysis

4 Industry Insights
4.1 Regulatory Organizations/ associations/ Consortiums
4.2 Patent Landscape

5 Global Sports Medicine (by Product)
5.1 Body Reconstruction and Repair Devices
5.1.1 Implants
5.1.2 Arthroscopy Devices
5.1.3 Repair Devices
5.1.4 Orthobiologics
5.2 Body Support and Recovery Devices
5.3 Accessories

6 Global Sports Medicine Market, (by Application)
6.1 Knee
6.2 Shoulder
6.3 Foot and Ankle
6.4 Hip
6.5 Elbow and Wrist
6.6 Others

7 Global Sports Medicine Market (by Region)
7.1 North America
7.1.1 The U.S.
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 The U.K.
7.2.3 France
7.2.4 Spain
7.2.5 Italy
7.2.6 Austria
7.2.7 Switzerland
7.2.8 Belgium
7.2.9 The Netherlands
7.2.10 Sweden
7.2.11 The Rest-of-Europe
7.3 Asia-Pacific
7.3.1 China
7.3.2 Japan
7.3.3 India
7.3.4 South Korea
7.3.5 New Zealand
7.3.6 Australia
7.3.7 The Rest-of-Asia-Pacific
7.4 Latin America
7.4.1 Brazil
7.4.2 Mexico
7.4.3 Rest-of-Latin America
7.5 The Rest-of-the-World (RoW)
7.5.1 Saudi Arabia
7.5.2 The U.A.E.
7.5.3 Russia
7.5.4 Israel
7.5.5 Others

8 Company Profiles
8.1 Overview
8.2 Arthrex, Inc.
8.2.1 Company Overview
8.2.2 Role of Arthrex, Inc.in the Sports Medicine Market
8.2.3 SWOT Analysis
8.3 Bioventus LLC
8.3.1 Company Overview
8.3.2 Role of Bioventus LLC in Sports Medicine Market
8.3.3 SWOT Analysis
8.4 Breg, Inc.
8.4.1 Company Overview
8.4.2 Role of Breg, Inc. in Sports Medicine Market
8.4.3 SWOT Analysis
8.5 Ceterix Orthopaedics Inc.
8.5.1 Company Overview
8.5.2 Role of Ceterix Orthopaedics Inc. in Sports Medicine Market
8.5.3 SWOT Analysis
8.6 ConMed Corporation
8.6.1 Company Overview
8.6.2 Role of ConMed Corporation in Sports Medicine Market
8.6.3 Financials
8.6.4 Key Insights about Financial Health of the Company
8.6.5 SWOT Analysis
8.7 DJO, LLC
8.7.1 Company Overview
8.7.2 Role of DJO, LLC in Sports Medicine market
8.7.3 SWOT Analysis
8.8 General Electric Company
8.8.1 Company Overview
8.8.2 Role of General Electric Company in the Sports Medicine Market
8.8.3 Financials
8.8.4 Key Insights about Financial Health of the Company
8.8.5 SWOT Analysis
8.9 JOHNSON & JOHNSON
8.9.1 Company Overview
8.9.2 Role of Johnson & Johnson in Sports Medicine Market
8.9.3 Financials
8.9.4 Key Insights about the Financial Health of the Company
8.9.5 SWOT Analysis
8.10 Mueller Sports Medicine, Inc.
8.10.1 Company Overview
8.10.2 Role of Mueller Sports Medicine, Inc. in Sports Medicine Market
8.10.3 SWOT Analy sis
8.11 Osiris Therapeutics, Inc.
8.11.1 Company Overview
8.11.2 Role of Osiris Therapeutics, Inc. in Sports Medicine Market
8.11.3 Financials
8.11.4 Key Insights About the Financial Health of the Company
8.11.5 SWOT Analysis
8.12 RTI Surgical, INC.
8.12.1 Company Overview
8.12.2 Role of RTI Surgical, INC. in the Sports Medicine Market
8.12.3 Financials
8.12.4 Key Insights About Financial Health of the Company
8.12.5 SWOT Analysis
8.13 Smith & Nephew plc
8.13.1 Company Overview
8.13.2 Role of Smith & Nephew plc, Inc. in Sports Medicine Market
8.13.3 Financials
8.13.4 Key Insights About the Financial Health of Company
8.13.5 SWOT Analysis
8.14 Stryker Corporation
8.14.1 Company Overview
8.14.2 Role of Stryker Corporation in the Sports Medicine Market
8.14.3 Financials
8.14.4 Key Insights About Financial Health of the Company
8.14.5 SWOT Analysis
8.15 Wright Medical Group N.V.
8.15.1 Company Overview
8.15.2 Role of Wright Medical Group N.V. Company in Sports Medicine Market
8.15.3 Financials
8.15.4 Key Insights About Financial Health of the Company
8.15.5 SWOT Analysis
8.16 Zimmer Biomet Holdings, INC.
8.16.1 Company Overview
8.16.2 Role of Zimmer Biomet Holdings in Sports Medicine Market
8.16.3 Financials
8.16.4 Key Insights About the Financial Health of the Company
8.16.5 SWOT Analysis

9 Research Scope and Methodology
9.1 Scope of the Report
9.2 Global Sports Medicine Market Segmentation
9.3 Research Methodology
9.3.1 Primary Research
9.3.2 Secondary Research
9.3.3 Key Data Points from Primary and Secondary Sources
9.3.4 Data Triangulation
9.3.5 Top-Down Approach
9.3.6 Bottom- Up Approach
9.4 Assumptions and Limitations



List of Tables




Table 1: Impact analysis of Market Drivers
Table 2: Impact Analysis of Market Restraints
Table 1.1: Incidents of Concussion from 2012 to 2017, as per National Football League
Table 1.2: Most Common Sports Injuries
Table 2.1: New Products and Recent Developments of Major Companies
Table 2.2: Some of the Orthobiologic Products by Different Companies
Table 3.1: Clinical Studies (by Company), 2015-2018
Table 3.2: Other strategies (By Company), 2015-2018
Table 5.1: Global Market of Body Reconstruction and Repair Products, for Knee Injury ($Million)
Table 5.2: Global Market of Body Reconstruction and Repair Products, for Shoulder Injury ($Million)
Table 5.3: Global Market of Body Reconstruction and Repair Products, for Hip Injury ($Million)
Table 5.4: Global Market of Body Reconstruction and Repair Products, for Foot and Ankle Injury ($Million)
Table 5.5: Global Market of Body Reconstruction and Repair Products, for Elbow and Wrist Injury ($Million)
Table 7.1: Sports Injuries in 2015, by number
Table 7.2: Hospitalization due to Sports Injuries in Canada, 2016-2017
Table 7.3: Incidence Rate of Sports Injuries for European Countries, 2013-2015
Table 7.4: Brazil Estimated Injury Rates in 2015
Table 8.1: Osiris Therapeutics, Inc.: Product Portfolio

List of Figures




Figure 1: Global Sports Medicine Market, 2018 and 2026
Figure 2: Global Sports Medicine Market (by Product), 2018 and 2026
Figure 3: Global Sports Medicine Market (by Application), 2018 and 2026
Figure 4: Global Sports Medicine Market (by Region), 2017 and 2028
Figure 5: Global Sports Medicine Market by Region, 2026
Figure 2.1: Market Dynamics
Figure 3.1: Share of Key Developmental Strategies, 2015-2018
Figure 3.2: Product Launch (By Company), 2015-2018
Figure 3.3: Acquisitions (by Company), 2015-2018
Figure 3.4: Agreements, Collaborations and Partnerships (By Company), 2015-2018
Figure 3.5: Global Sports Medicine Market Share, 2017 and 2018
Figure 3.6: Global Sports Medicine Market by Company, 2018
Figure 4.1: Share of Patents by Ownership, 2015-2018
Figure 5.1: Sports Medicine Market, (by Product)
Figure 5.2: Global Sports Medicine Market, 2017-2026
Figure 5.3: Global Body Reconstruction and Repair Devices Market, 2017-2026
Figure 5.5: Global Body Support and Recovery Devices Market, 2017-2026
Figure 5.6: Global Accessories Market, 2017-2026
Figure 6.1: Global Sports Medicine Market, (by Knee Injuries), 2017-2026
Figure 6.2: Global Sports Medicine Market, (by Shoulder injury), 2017-2026
Figure 6.3: Global Sports Medicine Market, (By Foot and Ankle injury), 2017-2026
Figure 6.4: Global Sports Medicine Market, (by Hip Injuries), 2017-2026
Figure 6.5: Global Sports Medicine Market, (by Wrist and Elbow Injuries), 2017-2026
Figure 6.6: Global Sports Medicine Market, (By Other Injuries), 2017-2026
Figure 7.1: Global Sports Medicine Market (By Region)
Figure 7.2: Global Sports Medicine Market (By Region)
Figure 7.3: North America Sports Medicine Market, 2017-2026
Figure 7.4: The U.S. Sports Medicine Market, 2017-2016
Figure 7.5: Canada Sports Medicine Market, 2017-2026
Figure 7.6: European Sports Medicine Market, 2017-2026
Figure 7.7: Germany Sports Medicine Market, 2017-2026
Figure 7.8: The U.K. Sports Medicine Market, 2017-2026
Figure 7.9: France Sports Medicine Market, 2017-2026
Figure 7.10: Spain Sports Medicine Market, 2017-2026
Figure 7.11: Italian Sports Medicine Market, 2017-2026
Figure 7.12: Austria Sports Medicine Market, 2018-2026
Figure 7.13: Switzerland Sports Medicine Market, 2017-2026
Figure 7.14: Belgium Sports Medicine Market, 2017-2026
Figure 7.15: The Netherlands Sports Medicine Market, 2018-2028
Figure 7.16: Sweden Sports Medicine Market, 2017-2026
Figure 7.17: Rest-of-Europe Sports Medicine Market, 2017-2026
Figure 7.18: Asia-Pacific Sports Medicine Market, 2017-2026
Figure 7.19: China Sports Medicine Market, 2017-2026
Figure 7.20: Japan Sports Medicine Market, 2017-2026
Figure 7.21: Indian Sports Medicine Market, 2017-2026
Figure 7.22: South Korea Sports Medicine Market, 2017-2026
Figure 7.23: New Zealand Sports Medicine Market, 2017-2026
Figure 7.24: Australia Sports Medicine Market, 2017-2026
Figure 7.25: The Rest-of-asia-Pacific Sports Medicine Market, 2017-2026
Figure 7.26: Latin America Sports Medicine Market, 2017-2026
Figure 7.27: Brazil Sports Medicine Market, 2017-2026
Figure 7.28: Mexico Sports Medicine Market, 2017-2026
Figure 7.29: The Rest-of-Latin America Sports Medicine Market, 2017-2026
Figure 7.30: The RoW Sports Medicine Market, 2017-2026
Figure 7.31: Saudi Arabia Sports Medicine Market, 2017-2026
Figure 7.32: The U.A.E. Sports Medicine Market, 2017-2026
Figure 7.33: Russia Sports Medicine Market, 2017-2026
Figure 7.34: Israel Sports Medicine Market, 2017-2026
Figure 7.35: Others Sports Medicine Market, 2017-2026
Figure 8.1 Company Profiles, (By Ownership)
Figure 8.2: Arthrex, Inc.: Sports Medicine Product Portfolio
Figure 8.3: Arthrex, Inc.: SWOT Analysis
Figure 8.4: Bioventus LLC: Product Portfolio
Figure 8.5: Bioventus LLC: SWOT Analysis
Figure 8.6: Breg, Inc.: Product Portfolio
Figure 8.7: Breg, Inc.: SWOT Analysis
Figure 8.8: Ceterix Orthopaedics Inc.: SWOT Analysis
Figure 8.9: CONMED Corporation: Sports Medicine Product Portfolio
Figure 8.10: CONMED Corporation: Overall Financials, 2015-2017
Figure 8.11: CONMED Corporation: Revenue (by Business Segment), 2015-2017
Figure 8.12: CONMED Corporation: Revenue (by Region), 2015-2017
Figure 8.13: CONMED Corporation: R&D Expenditure, 2015-2017
Figure 8.14: CONMED Corporation PLC: SWOT Analysis
Figure 8.15: DJO, LLC: SWOT Analysis
Figure 8.16: General Electric Company: Overall Product Portfolio
Figure 8.17: General Electric Company: Overall Financials, 2015-2017
Figure 8.18: General Electric Company: Revenue (by Segment), 2015-2017
Figure 8.19: General Electric Company: Revenue (by Sub-Segment), 2016-2017
Figure 8.20: General Electric Company: Revenue (by Region), 2015-2017
Figure 8.21: General Electric Company: R&D Expenditure, 2015-2017
Figure 8.22: General Electric Company: SWOT Analysis
Figure 8.23: Johnson & Johnson : Overall Financials, 2015-2017
Figure 8.24: Johnson & Johnson (by Business Segment), 2015-2017
Figure 8.25: Johnson & Johnson (by Region), 2015-2017
Figure 8.26: Johnson & Johnson : Research and Development Expense, 2015-2017
Figure 8.27: Johnson & Johnson: SWOT ANALYSIS
Figure 8.28: Mueller Sports Medicine, Inc.: Sports Medicine Product Portfolio
Figure 8.29: Mueller Sports Medicine, Inc.: SWOT Analysis
Figure 8.30: Osiris Therapeutics, Inc.: Overall Financials, 2015-2017
Figure 8.31: Osiris Therapeutics, Inc. (by Product), 2015-2017
Figure 8.32: Osiris Therapeutics, Inc.: Research and Development Expense, 2015-2017
Figure 8.33: Osiris Therapeutics, Inc.: SWOT Analysis
Figure 8.34: RTI Surgical, INC.: Sports Medicine Product Portfolio
Figure 8.35: RTI Surgical, INC.: Overall Financials
Figure 8.36: RTI Surgical, INC.: Revenue (by Business Segment), 2015-2017
Figure 8.37: RTI Surgical, INC.: Revenue (by Region), 2015-2017
Figure 8.38: RTI Surgical, INC.: R&D Expenditure, 2015-2017
Figure 8.39: RTI Surgical, INC.: SWOT Analysis
Figure 8.40: Smith & Nephew: Product Portfolio
Figure 8.41: Smith & Nephew plc, Inc.: Overall Financials
Figure 8.42: Smith & Nephew plc (by Business Segment), 2015-2017
Figure 8.43: Smith & Nephew plc (by Region), 2015-2017
Figure 8.44: Smith & Nephew plc: Research and Development Expense, 2015-2017
Figure 8.45: Smith & Nephew plc: SWOT Analysis
Figure 8.46: Stryker Corporation: Sports Medicine Product Portfolio
Figure 8.47: Stryker Corporation: Overall Financials
Figure 8.48: Stryker Corporation: Revenue (by Business Segment), 2015-2017
Figure 8.49: Stryker Corporation: Revenue (by Region), 2015-2017
Figure 8.50: Stryker Corporation R&D Expenditure, 2015-2017
Figure 8.51: Stryker Corporation: SWOT Analysis
Figure 8.52: Wright Medical Group N.V.: Overall Financials, 2015-2017
Figure 8.53: Wright Medical Group N.V. (by Business Segments), 2015-2017
Figure 8.54: Wright Medical Group N.V. (by Region), 2015-2017
Figure 8.55: Wright Medical Group N.V.: Research and Development Expenditure, 2015-2017
Figure 8.56: Wright Medical Group N.V.: SWOT Analysis
Figure 8.57: Zimmer Biomet Holdings, Inc: Sports Medicine Product Portfolio
Figure 8.58: Zimmer Biomet Holdings, Inc: Overall Financials, 2015-2017
Figure 8.59: Zimmer Biomet Holdings, Inc.: Revenue (by Business Segment), 2015-2017
Figure 8.60: Zimmer Biomet Holdings, INC.: Revenue (by Region), 2015-2017
Figure 8.61: Zimmer Biomet Holdings, Inc: Research and Development Expense, 2015-2017
Figure 8.62: Zimmer Biomet Holdings, Inc: SWOT Analysis
Figure 9.1: Global Sports Medicine Market Segmentation
Figure 9.2: Research Methodology
Figure 9.3: Key Data Points from Primary and Secondary Sources
Figure 9.4: Key Data Points from Secondary Sources
Figure 9.5 Data Triangulation
Figure 9.6: Top-down Approach: Global Sports Medicine Market
Figure 9.7: Bottom-up Approach: Global Sports Medicine Market
Figure 9.8: Assumptions and Limitations